E-LIB Suche - Ergebnisse für: Pascual-Pasto, Guillem

1

Low Bcl-2 is a robust biomarker of sensitivity to nab-pacli..:

Pascual-Pasto, Guillem ; Resa-Pares, Claudia ; Castillo-Ecija, Helena...
Biochemical Pharmacology. 208 (2023) - p. 115408 , 2023

Link: https://doi.org/10.1016/..

2

MIF/CXCR4 signaling axis contributes to survival, invasion,..:

Garcia-Gerique, Laura ; García, Marta ; Garrido-Garcia, Alícia...
BMC Cancer. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

3

Epigenetic state determines inflammatory sensing in neurobl..:

Wolpaw, Adam J. ; Grossmann, Liron D. ; Dessau, Jessica L....
Proceedings of the National Academy of Sciences. 119 (2022) 6 - p. , 2022

Link: https://doi.org/10.1073/..

4

GPC2-CAR T cells tuned for low antigen density mediate pote..:

Heitzeneder, Sabine ; Bosse, Kristopher R. ; Zhu, Zhongyu...
Cancer Cell. 40 (2022) 1 - p. 53-69.e9 , 2022

Link: https://doi.org/10.1016/..

5

SPARC-mediated long-term retention of nab-paclitaxel in ped..:

Pascual-Pasto, Guillem ; Castillo-Ecija, Helena ; Unceta, Nora...
Journal of Controlled Release. 342 (2022) - p. 81-92 , 2022

Link: https://doi.org/10.1016/..

6

GPC2 antibody–drug conjugate reprograms the neuroblastoma i..:

Pascual-Pasto, Guillem ; McIntyre, Brendan ; Shraim, Rawan...
Journal for ImmunoTherapy of Cancer. 10 (2022) 12 - p. e004704 , 2022

Link: https://doi.org/10.1136/..

7

Selective inhibition of HDAC6 regulates expression of the o..:

García-Domínguez, Daniel J. ; Hajji, Nabil ; Sánchez-Molina, Sara...
Oncogene. 40 (2021) 39 - p. 5843-5853 , 2021

Link: https://doi.org/10.1038/..

8

Treatment-driven selection of chemoresistant Ewing sarcoma ..:

Castillo-Ecija, Helena ; Monterrubio, Carles ; Pascual-Pasto, Guillem...
Journal of Controlled Release. 324 (2020) - p. 440-449 , 2020

Link: https://doi.org/10.1016/..

9

The combination of epigenetic drugs SAHA and HCI-2509 syner..:

García-Domínguez, Daniel Jose ; Hontecillas-Prieto, Lourdes ; Rodríguez-Núñez, Pablo...
Oncotarget. 9 (2018) 59 - p. 31397-31410 , 2018

Link: https://doi.org/10.18632..

10

DIPG-49. STAT3 AS A THERAPEUTIC TARGET IN DIPG:

Olaciregui, Nagore G ; Carvalho, Diana ; Mackay, Alan...
Neuro-Oncology. 20 (2018) suppl_2 - p. i58-i59 , 2018

Link: https://doi.org/10.1093/..

11

Glucosylated nanomicelles target glucose-avid pediatric pat..:

Bukchin, Alexandra ; Pascual-Pasto, Guillem ; Cuadrado-Vilanova, Maria...
Journal of Controlled Release. 276 (2018) - p. 59-71 , 2018

Link: https://doi.org/10.1016/..

12

Correction: The PARP inhibitor olaparib enhances the sensit..:

Ordóñez, José Luis ; Amaral, Ana Teresa ; Carcaboso, Angel M....
Oncotarget. 8 (2017) 26 - p. 43592-43592 , 2017

Link: https://doi.org/10.18632..

13

Increased delivery of chemotherapy to the vitreous by inhib..:

Pascual-Pasto, Guillem ; Olaciregui, Nagore G. ; Opezzo, Javier A.W....
Journal of Controlled Release. 264 (2017) - p. 34-44 , 2017

Link: https://doi.org/10.1016/..

14

Targeted drug distribution in tumor extracellular fluid of ..:

Monterrubio, Carles ; Paco, Sonia ; Olaciregui, Nagore G....
Journal of Controlled Release. 255 (2017) - p. 108-119 , 2017

Link: https://doi.org/10.1016/..

15

Schedule-Dependent Antiangiogenic and Cytotoxic Effects of ..:

Winter, Ursula ; Mena, Hebe A. ; Negrotto, Soledad...
PLOS ONE. 11 (2016) 7 - p. e0160094 , 2016

Link: https://doi.org/10.1371/..